Cure My Disease

Don't miss your cure!

 Log in / Sign up

Training with surprise slips may teach stroke survivors to prevent falls

NCT ID NCT03205527

Disease control Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing This study
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 08, 2026 · Last updated Jul 09, 2026 · Updated 1 time

Summary

This trial tests whether a special training that uses unexpected slips on a low-friction platform can help stroke survivors improve their balance and reduce falls. Participants will practice recovering from slips in a safe lab setting, and researchers will track whether these skills carry over to everyday life. The goal is to develop a simple, effective way to lower fall risk and improve walking function in people who have had a stroke.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Overground slip perturbation training
What this could lead to
If it works, this training could become a standard therapy to help stroke survivors prevent falls and regain safer walking.
What could go wrong
This is a small, early-stage study. The training may not translate to real-world falls, and results may not apply to all stroke survivors.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

91 people

The number who actually took part.

Started

Apr 2017

Expected to finish

Mar 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

21 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Subjects will have to be ambulatory (with or without assistive device) with self-reported chronic (\> 6 months) stroke-induced hemiparesis confirmed by participants' physician and medically cleared. Evidence of unilateral brain lesion confirmed by an imaging study (e.g. CT or MRI). * Subjects with no other acute and significant neurological, cardiopulmonary, musculoskeletal or systemic diagnosis or have undergone a recent major surgery (\<6 months) or hospitalization (\<3 months) and not on any sedative drugs * Ability to walk at least 10m with or without assistive device which includes use of ankle orthosis or functional electrical stimulation devices (which is equivalent to having a score of\> 4, dependent supervision on Functional Ambulatory category scale) Exclusion Criteria: * Severe osteoporosis (Ultrasound score \< -2) * Cognitive impairment (Mini Mental State Exam score\<25) * Aphasia (\<71% on Mississippi Aphasia Screening Test) * Severe depression ( \> 15 on Geriatric Depression Scale) * Severe obesity (BMI \>35Kilogram/m2) * Complains of shortness of breath, or uncontrolled pain (\> 3/10 on VAS), or if pulse oxygen drops \<92% on the 6 minute walk test (for endurance) * Uncontrolled hypertension (resting systolic blood pressure \> 165 mmHg and/or diastolic blood pressure \> 110mmHg) * Resting heart rate \> 85% of age-predicted maximal heart rate * Resting oxygen saturation \<95%

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • University of Illinois at Chicago

    Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.